MAR 02, 2022 8:16 AM PST

Bacteria in the Lungs Can Impact Immune Cells in the Brain

WRITTEN BY: Carmen Leitch

Research has revealed that nearly the entire human body has been colonized by microbes. While studies have shown just how closely we are connected to the microbes in the body, some of those connections are still surprising. For example, though small, there is a community of microbes in the lungs. While the composition and function of the lung microbiome is still under investigation, new research reported in Nature has revealed that there seems to be a close link between the lung microbiome and the brain.

Microglia can be seen here in green, cropped from an image by Laura Sebastian Monasor eLife 2020 / CC4.0 https://creativecommons.org/licenses/by/4.0/

The lung microbiome appears to influence the activity of immune cells in the brain called microglia. The lung microbiome can impact the risk of autoimmune inflammation in the brain. That type of inflammation has been observed in several diseases including multiple sclerosis.

Microbes in the lung appear to send signals to microglia in the brain, which can then react rapidly to threats, explained first study author Dr. Leon Hosang of the University Medical Center Göttingen.

"The lung microbiome can, therefore, be seen as an early warning system for the sensitive brain tissue," added co-senior study author Francesca Odoardi, Heisenberg Professor at University Medical Center Göttingen.

Many environmental influences could be affecting immunity in the brain this way, like lung infections, air pollution, or antibiotics that affect the lung microbiome, for example. Smoking is also known to increase the risk of multiple sclerosis, an autoimmune disorder. It may also be possible to target the lung-brain axis for therapeutic use.

"For example, a dosage of probiotics or specific antibiotics could be used to influence the brain's immune reaction in a targeted fashion in order to treat not only multiple sclerosis but also diseases of the central nervous system in general where the immune activity of microglia plays a role," suggested co-senior study author Alexander Flügel, a Professor at the University Medical Center Göttingen.

Although not many microbes can be found in the lungs, they seem to be sensitive to changes that occur. A local, low dose of antibiotics in a mouse model was enough to cause changes in the risk of autoimmune disease in the brain. When the researchers exposed the mouse lung microbiome to antibiotics, they found that microglia in the brain were then altered. Microglia have fine branches, and changes could be seen under a microscope. Those branches became shorter and thicker after the antibiotic treatment and the microglia had a weaker reaction to inflammatory signals. That drew fewer immune cells to the site of inflammation.

Bacteria in the lungs generate a molecule that makes up part of their cell wall, a lipopolysaccharide. This molecule began to build up in lung tissue after antibiotic exposure. The weak microglial response and autoimmune resistance were triggered by increased levels of lipopolysaccharide. When lipopolysaccharide levels in the lungs were reduced, however, the autoimmune disease got worse.

Sources: University Medical Center Göttingen, Nature

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 22, 2022
Health & Medicine
Back to Nature: the Health Benefits of Nature Prescriptions
MAR 22, 2022
Back to Nature: the Health Benefits of Nature Prescriptions
With modern amenities and luxuries, it's easy to be unaware of just how much we may neglect the outdoors and its hea ...
APR 01, 2022
Drug Discovery & Development
Pill Form of Remdesivir Treats COVID-19 in Mice
APR 01, 2022
Pill Form of Remdesivir Treats COVID-19 in Mice
A pill form of remdesivir, an antiviral drug currently administered intravenously, may be able to treat COVID-19 in mice ...
JUN 01, 2022
Clinical & Molecular DX
Personalized Cancer Vaccine Showing Promise in Treating Melanoma and Ovarian Cancer
JUN 01, 2022
Personalized Cancer Vaccine Showing Promise in Treating Melanoma and Ovarian Cancer
Cancer vaccines have been around for decades, but a unique neoantigen vaccine called NeoVax is making researchers hopefu ...
MAY 20, 2022
Health & Medicine
Taboo Bird Flu Vaccines Considered in Europe Amid Poultry Outbreak
MAY 20, 2022
Taboo Bird Flu Vaccines Considered in Europe Amid Poultry Outbreak
Vaccines are yet again a subject of controversy, but this time it's got nothing to do with COVID. An outbreak of avi ...
JUN 06, 2022
Drug Discovery & Development
New Antibiotic Shows Promise Against Treatment-Resistant Tuberculosis
JUN 06, 2022
New Antibiotic Shows Promise Against Treatment-Resistant Tuberculosis
A new class of antibiotics has shown promise in preclinical trials against drug-resistant tuberculosis. The correspondin ...
JUN 15, 2022
Drug Discovery & Development
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
JUN 15, 2022
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
High-intensity-focused ultrasound (HIFU) can treat some men with prostate cancer instead of surgery or radiation therapy ...
Loading Comments...